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Background
Acetazolamide (AZA), the only drug generally approved
for hydrocephalus, is effective in only 25-30% of
patients, and its effect on basal fluid flow in choroid
plexus (CP) is unknown. The drug reversibly inhibits
Aquaporin 4 (AQP4), the most highly expressed ‘water
pore’ in the brain, and it is postulated that it reduces
CSF production by modulating the expression and/or
function of AQP1 (mostly found in the apical membrane
of CP). In this study, we sought to elucidate the direct
effect of AZA on basal fluid flow in CP.
Materials and methods
CP tissues were harvested from 10-day Sprague-Dawley
rat pups. CP cultures were grown to confluence in Trans-
well permeable supports and tested using: a) Kir 7.1
immunocytochemistry to confirm CP cell morphology;
b) Lucifer Yellow assay and trans-epithelial electrical
resistance (TEER) to determine level of confluence;
c) fluid assays using TRITC-labeled Dextran to assay
the direction and extent of fluid flow through the mono-
layers; d) expression of AQP1 protein by immunoblotting
and immunocytochemistry.
Results
Immunblotting and immunocytochemical analyses
showed that AQP1 protein level decreases rapidly with
10 um AZA treatment. The reduction of AQP1 protein
was transient as its level returned to baseline 12 hours
after AZA exposure. Transwell fluid assay indicated
that the early loss of AQP protein is correlated with
decreased basal fluid flow in CP.
Conclusions
The observed effect of AZA on AQP1 protein level
suggests that AZA can directly modulate basal fluid flow
in CP. The AZA induced effect in CP resulted in an initial
fluid flow into the basolateral side of the transwells, with
subsequent flow into the apical side of the CP membranes.
Our results indicate that modulating AQP1 function via
effectively targeted pharmaceuticals could potentially yield
new treatments for hydrocephalus.
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